Business Context and Reporting Period
This Form 6-K filing by Takeda Pharmaceutical Company Limited, dated November 12, 2021, reports on share repurchase activities for the period from October 1, 2021, to October 31, 2021. The document serves as a translation of a Share Repurchase Report filed with the Kanto Local Finance Bureau under Japanese law.
Key Financial Metrics
The filing does not provide standard financial performance metrics such as revenue, profit, cash flow, margins, or debt levels. The only financial data disclosed relates to capital allocation and share structure:
- Share Repurchase Authorization: A Board resolution approved on October 28, 2021, authorized the repurchase of up to 35,000,000 shares with a total budget of 100,000,000,000 JPY.
- Repurchase Period: The authorized repurchase window runs from November 2, 2021, to April 29, 2022.
- Treasury Shares: As of October 31, 2021, the company held 175,203 treasury shares out of 1,582,252,525 total issued shares.
- Repurchases in Reporting Month: The filing text does not provide a clear value for the number of shares or amount spent during the October 1–31, 2021 reporting period, as the specific data fields in the table are empty.
Material Changes
The filing does not disclose material changes in financial performance compared to prior periods. The primary update is the authorization of a new share repurchase program effective November 2, 2021, following the reporting period.
Guidance, Outlook, and Risks
The document contains no management commentary, financial guidance, or discussion of risks and contingencies. It is strictly a regulatory disclosure regarding the status of share repurchases and treasury holdings.
Investor Verification Checklist
- Verify the actual volume and cost of shares repurchased in October 2021, as the specific figures are missing from this text summary.
- Monitor the execution of the new 100 billion JPY repurchase program authorized for the period of November 2021 to April 2022.
- Confirm the exclusion of ESOP and BIP trust account shares from the reported treasury share count of 175,203.